DICE Therapeutics, Amgen And Some Other Big Stocks Moving Higher On Tuesday

Author: Lisa Levin | October 11, 2022 10:39am

U.S. stocks traded mostly lower, with the Nasdaq dropping more than 100 points on Tuesday. Here are some big stocks recording gains in today’s session.

• DICE Therapeutics, Inc. (NASDAQ:DICE) shares surged 53.6% to $37.86 after the company announced topline data from its Phase 1 clinical trial of DC-806. Clinical proof-of-concept in psoriasis patients achieved with a mean percentage reduction in PASI from baseline at 4 weeks of 43.7% in the high dose group.
• ForgeRock, Inc. (NYSE:FORG) gained 49.2% to $22.62 after the company announced it will be acquired by Thoma Bravo for $2.3 billion.
• Bright Health Group, Inc. (NYSE:BHG) jumped 24.7% to $1.1350.
• Albireo Pharma, Inc. (NASDAQ:ALBO) shares jumped 17.5% to $24.05 after the company announced topline results from the Phase 3 of Bylvay in Alagille syndrome showed highly statistically significant improvement in pruritus primary endpoint.
• Amprius Technologies, Inc. (NASDAQ:AMPX) surged 17.3% to $8.79. Amprius Technologies was awarded $1 million Department of Energy funding grant for advanced battery manufacturing.
• Braskem S.A. (NYSE:BAK) shares climbed 12.4% to $12.07 following a report suggesting Apollo has made a new offer for the company.
• Annaly Capital Management, Inc. (NYSE:NLY) gained 8% to $16.33.
• Douglas Elliman Inc. (NYSE:DOUG) surged 8% to $4.33.
• Cementos Pacasmayo S.A.A. (NYSE:CPAC) shares rose 7.2% to $4.88.
• Arbe Robotics Ltd. (NASDAQ:ARBE) gained 7% to $6.10.
• Amgen Inc. (NASDAQ:AMGN) surged 6.7% to $247.62 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $257 to $279.
• e.l.f. Beauty, Inc. (NYSE:ELF) rose 6.2% to $39.81. Piper Sandler upgraded e.l.f. Beauty from Neutral to Overweight and raised the price target from $35 to $46.

Posted In: ALBO AMGN AMPX ARBE BAK BHG CPAC DICE DOUG ELF FORG NLY